The global dry eye treatment devices market size is estimated to reach US$400.8 million by 2027, expanding at a CAGR of 6.4%, according to a new report by Grand View Research, Inc. The increasing demand for targeted, noninvasive, faster, and patient compliant treatment methods to alleviate dry eye symptoms are the factors expected to drive the market during the forecast period.
The rising incidence of causative risk factors such as overusage of contact lenses, prolonged exposure to digital screens, diabetes, glaucoma, and Sjogren’s syndrome is anticipated to propel market growth.
Key suggestions from the report:
- Meibomian gland expression technology held the largest market share in 2019 due to factors such as frequent product launches, cost-effectiveness, and improving accessibility.
- Intense pulsed light (IPL) and combination technologies are expected to grow at the fastest rate during the forecast period due to factors such as the development of economical and compact-sized IPL devices.
- The increasing number of clinical and research activities conducted to evaluate the safety and efficacy of advanced dry eye treatment devices will boost the growth of the market.
Read the full report from Grand View Research.